Event Specialty: Endourology
We’re thrilled to demo the MONARCH® Platform for use in endourologic procedures! This innovative robotic platform, owned by Ethicon, Inc., part of the Johnson & Johnson MedTech Companies, enables urologists to reach and visualize areas within the kidney.
The MONARCH® Platform, Urology is designed to elevate standard of care by providing urologists with one platform to support two common procedures used to remove stones – ureteroscopy and percutaneous nephrolithotomy (PCNL).
Come see a demo of the Monarch Platform, Urology in action. Use our specialized VR headset to experience the Monarch Platform set up in a urology suite!
AUA PRESENTATIONS FEATURING MONARCH ROBOTIC TEHCNOLOGY: SESSION Surgical Technology & Simulation: Instrumentation & Technology II May 15 | 7:00am–9:00am | Room 245 PRESENTER Thomas Chi, MD Robotic-Assisted Percutaneous Nephrolithotomy and Ureteroscopy with the MONARCH® Platform, Urology Compares Favorably Against Conventional Techniques
SESSION Uroradiology II May 15 | 9:30am–11:30am | Room 252 PRESENTER Mitchell R. Humphreys, MD Robotic-Assisted Electromagnetic Guidance Minimizes Radiation Exposure in Gaining Percutaneous Access for Nephrolithotomy: A Cadaveric Study with Novices
POSTERS May 13 | 2:45pm– 4:00pm | Room 225 Robotic-Assisted Electromagnetic Guidance Improves Success in Gaining Percutaneous Access for Nephrolithotomy by Novices
May 15 | 10:30am– 11:45am | Room 228 Novel Robotic-Assisted Electromagnetic Guidance for Precision Percutaneous Access: A Cadaveric Study of Novices Versus an Expert
The American Urological Association (AUA) 2022 Annual Meeting is the largest gathering of urologists in the world, providing unparalleled access to groundbreaking research, new guidelines and the latest advances in urologic medicine.Register for AUA 2022
Bronchoscopy Important Safety Statement:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology Important Safety Statement:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.